SYMBICORT (budesonide; formoterol fumarate dihydrate) Astrazeneca Patent: 7,967,011 Expiration: Feb 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Pa…
Drug Patent Expirations for the Week of February 6, 2022 Read Post »
SYMBICORT (budesonide; formoterol fumarate dihydrate) Astrazeneca Patent: 7,967,011 Expiration: Feb 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Pa…
Drug Patent Expirations for the Week of February 6, 2022 Read Post »
Annual Drug Patent Expirations for SELZENTRY Selzentry is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from one supplier. There are three patents…
The post New patent expiration for Viiv Hlthcare drug SELZENTRY appeared…
New patent expiration for Viiv Hlthcare drug SELZENTRY Read Post »
Annual Drug Patent Expirations for CAPRELSA Caprelsa is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Genzyme Corp drug CAPRELSA appeared first …
New patent expiration for Genzyme Corp drug CAPRELSA Read Post »
Annual Drug Patent Expirations for SPIRIVA+RESPIMAT Spiriva Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…
The post New patent expiration for Boehringer Ingelheim drug…
New patent expiration for Boehringer Ingelheim drug SPIRIVA RESPIMAT Read Post »
Annual Drug Patent Expirations for AURYXIA Auryxia is a drug marketed by Keryx Biopharms and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Keryx Biopharms drug AURYXIA appeared …
New patent expiration for Keryx Biopharms drug AURYXIA Read Post »
Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Gilead Sciences drug ODEFSEY appeared first on…
New patent expiration for Gilead Sciences drug ODEFSEY Read Post »
Annual Drug Patent Expirations for SYMTUZA Symtuza is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent expiration for Janssen Prods drug SYMTUZA appeared first on…
New patent expiration for Janssen Prods drug SYMTUZA Read Post »
Annual Drug Patent Expirations for VEMLIDY Vemlidy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are four…
The post New patent expiration for Gilead Sciences drug VEMLIDY appeared first o…
New patent expiration for Gilead Sciences drug VEMLIDY Read Post »
Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are thirteen…
The post New patent expiration for Gilead Sciences drug BIKTARVY appeared…
New patent expiration for Gilead Sciences drug BIKTARVY Read Post »